Even with risky survival rate, shortages of ECMO machines cost lives, study finds

Nurses at Ascension Saint Thomas in Nashville stand in the hallway of an ICU as patients receive ECMO therapy during the delta variant surge of late summer 2021.

For COVID patients, ECMO is a last-ditch respiratory treatment in which only about half survive. Yet a new small study suggests many lives would still have been saved if there had been more machines.

(Image credit: Blake Farmer/WPLN News)

Read the full post on Health Care : NPR